Browse drugs

…gence) assistance), and exploring complementary strategies (eg, aspirin chemoprevention, biomarker-guided risk) are priorities. This na…

… extended model incorporating MALAT1. cfNRI for the addition of MALAT1 was 0.530 (95% CI 0.104 to 0.910), indicating significant enhan…

…lity risk. On PAH diagnosis, RD patients were less treated with endothelin receptor antagonists (61% vs 69%, p=0.04) and more with single PAH therapy (55% vs 4…

…eyes. CVI was computed from subfoveal OCT B-scans acquired with Heidelberg Spectralis at baseline and at 60 months. ΔCVI was defined as the differenc…

… National Health Service Trusts in the UK. Patients with active Charcot neuro-osteoarthropathy, active DFU or ulcers healed for more than 12 weeks will be exc…

…ded microvasculature was observed following the introduction of sirolimus.This case provides longitudinal in vivo evidence for the involv…

… of children aged 5–15 years (31.9%) and the need for long-term penicillin prophylaxis (28.5%). In contrast, general awareness of preventi…

…bilateral pulmonary emboli and appearances consistent with BAH. Intravenous hydrocortisone was started resulting in a drastic improvement in her condition…

…e of topical benzyl benzoate and environmental decontamination. Ivermectin was unavailable due to national supply chain disruptions. The p…

…ere still with us he would now be painting his subjects with a “GLP-1 face,” says the paediatric endocrinologist Michael Yafi.…

… India in 2023 who received at least one packed red blood cell (PRBC) transfusion. Outborn babies who were transferred to the NICU b…

…une evasion. Crucially, pharmacological inhibition of NRF2 with ML385 restored cell surface MHC-I levels and sensitised PTEN-deficien…